TY  - GEN
AU  - Persky,Daniel O
AU  - Unger,Joseph M
AU  - Spier,Catherine M
AU  - Stea,Baldassarre
AU  - LeBlanc,Michael
AU  - McCarty,Matthew J
AU  - Rimsza,Lisa M
AU  - Fisher,Richard I
AU  - Miller,Thomas P
TI  - Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014
SN  - 1527-7755
PY  - 2008///0527
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Lymphoma, B-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prednisone
KW  - Rituximab
KW  - Vincristine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1200/JCO.2007.13.6929
ER  -